A Study of HRS2543 in Patients With Advanced Tumors
Clinical trial NCT05068856 · TERMINATED
Trial details
- NCT number
- NCT05068856
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2024-05-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.